| Autor: |
Rolnik, DL, Papageorghiou, AT |
| Předmět: |
|
| Zdroj: |
BJOG: An International Journal of Obstetrics & Gynaecology; Jan2021, Vol. 128 Issue 2, p166-166, 1p |
| Abstrakt: |
How sFlt-1 can help after pre-eclampsia diagnosis Measurement of maternal serum soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF), and the ratio between the two, has been shown to predict pre-eclampsia. In women with suspected pre-eclampsia, an sFlt-1: PlGF ratio <38 rules out the need for delivery in the subsequent week with a negative predictive value of 99.3% (95% CI 97.9-99.9%) (Zeisler et al. I N Engl J Med i 2016;374:13-22). [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text